IMN || Men's Health

Erectile dysfunction meds’ link to melanoma not causal

The erectile dysfunction agents sildenafil, vardenafil, and tadalafil showed a modest but significant association with increased risk of malignant melanoma in a large Swedish cohort study, but the...

Field of Interest: Oncology
Type: News Item

Urine assay ruled out high-grade prostate cancer

NEW ORLEANS – A urine assay test can provide a high negative predictive value to rule out the presence of high-grade, clinically significant prostate cancer without the need for a digital rectal exam...

Field of Interest: Oncology
Type: News Item

Prostate cancer screening for men over 50 has declined

Subsequent to the 2012 U.S. Preventative Services Task Force recommendation discouraging prostate-specific antigen (PSA)-based screening, prostate cancer screening significantly declined among men...

Field of Interest: Oncology
Type: News Item

Research IDs new subtype of refractory prostate cancer

CHICAGO – Researchers have identified a new histologic subset of metastatic castration-resistant prostate cancer called intermediate atypical carcinoma. “Despite being cytologically bland, this is...

Field of Interest: Oncology
Type: News Item

AACR: Biomarker of response to olaparib found

A phase II study evaluating single-agent olaparib in metastatic, castration-resistant prostate cancer offers the first evidence that genetic testing c... More »

Field of Interest: Oncology
Type: News Item

Pages

Subscribe to RSS - IMN || Men's Health